Reference
Jiwa N, et al. A case series of hereditary neuromuscular disorders in patients with neuromuscular immune-related adverse events secondary to immune checkpoint inhibitors. Muscle and Nerve 60 (Suppl. 1): S43, Sep 2019. Available from: URL: https://onlinelibrary.wiley.com/toc/10974598/2019/60/S1 [abstract]
Rights and permissions
About this article
Cite this article
Ipilimumab/nivolumab/pembrolizumab. Reactions Weekly 1840, 228 (2021). https://doi.org/10.1007/s40278-021-90371-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-90371-z